Details for New Drug Application (NDA): 021527

✉ Email this page to a colleague

NDA 021527 describes ATROVENT HFA, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ATROVENT HFA profile page.

The generic ingredient in ATROVENT HFA is ipratropium bromide. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

Summary for 021527

Tradename:	ATROVENT HFA
Applicant:	Boehringer Ingelheim
Ingredient:	ipratropium bromide
Patents:	1

Pharmacology for NDA: 021527

Mechanism of Action	Cholinergic Antagonists

Medical Subject Heading (MeSH) Categories for 021527

Bronchodilator Agents
Cholinergic Antagonists

Suppliers and Packaging for NDA: 021527

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0087	0597-0087-17	1 CANISTER in 1 CARTON (0597-0087-17) / 200 AEROSOL, METERED in 1 CANISTER
ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527	NDA	RPK Pharmaceuticals, Inc.	53002-8410	53002-8410-1	1 CANISTER in 1 CARTON (53002-8410-1) / 200 AEROSOL, METERED in 1 CANISTER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL, METERED;INHALATION			Strength	0.021MG/INH
Approval Date:	Nov 27, 2004	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Jan 17, 2030	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 021527

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.